IIM
HRMY icon

INTECH Investment Management’s Harmony Biosciences HRMY Stock Holding History

INTECH Investment Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.76M Buy
75,851
+3,559
+5% +$112K 0.03% 586
2026
Q1 		$2.02M Buy
72,292
+55,400
+328% +$1.82M 0.02% 697
2025
Q4 		$632K Sell
16,892
-3,188
-16% -$105K 0.01% 1377
2025
Q3 		$553K Sell
20,080
-4,068
-17% -$140K ﹤0.01% 1520
2025
Q2 		$763K Buy
24,148
+5,931
+33% +$191K 0.01% 1363
2025
Q1 		$605K Buy
18,217
+6,370
+54% +$228K 0.01% 1515
2024
Q4 		$408K Buy
11,847
+2,138
+22% +$73.5K ﹤0.01% 1679
2024
Q3 		$388K Buy
+9,709
New +$341K ﹤0.01% 1365

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

INTECH Investment Management's HRMY Position: Q2 2026 in Review

INTECH Investment Management increased its Harmony Biosciences (HRMY) stake by 4.9% in Q2 2026, buying an estimated $112K and bringing the position to 75,851 shares worth $2.76M. The position accounts for 0.03% of the portfolio, ranked #586.

INTECH Investment Management first reported a position in HRMY in Q3 2024 and has held it in 8 quarters since. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • INTECH Investment Management held 75,851 shares of Harmony Biosciences worth $2.76M as of Q2 2026.
  • INTECH Investment Management bought 3,559 Harmony Biosciences shares in Q2 2026, an estimated $112K.
  • Harmony Biosciences made up 0.03% of INTECH Investment Management's portfolio in Q2 2026, its #586 holding.
  • INTECH Investment Management first reported a position in Harmony Biosciences in Q3 2024 and has held it in 8 quarters since.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.